Jump to main content
Jump to site search

Issue 4, 2008
Previous Article Next Article

Evolution of polyketides: post-PKS processing in the formation of spiroketals

Author affiliations

Abstract

Covering: up to December 2007

It is now well recognized that natural products have directly or indirectly contributed to the discovery and development of as much as 75% of our current treatments for cancer and infectious disease as well as other indications. It cannot be overemphasized that new sources of chemical diversity are essential to the discovery of the next generation of chemotherapeutic agents. Characterization of the polyketide gene clusters responsible for the production of the spirangienes A and B provided detailed information regarding the biochemistry of myxobacterial secondary metabolism as well as significant insights into the evolution of post-PKS enzymes. The implications of these findings, coupled with additional examples, suggest that putative PKS products represent a new source of chemical diversity with chemotherapeutic potential and are thus worthy of further investigation.

Graphical abstract: Evolution of polyketides: post-PKS processing in the formation of spiroketals

Back to tab navigation

Publication details

The article was received on 10 Dec 2007 and first published on 01 May 2008


Article type: Highlight
DOI: 10.1039/B719088N
Nat. Prod. Rep., 2008,25, 651-655

  •   Request permissions

    Evolution of polyketides: post-PKS processing in the formation of spiroketals

    J. Young and R. E. Taylor, Nat. Prod. Rep., 2008, 25, 651
    DOI: 10.1039/B719088N

Search articles by author

Spotlight

Advertisements